Clinical studies demonstrate minimal impact on cortisol levels (unlike GHRP-6 and GHRP-2), negligible prolactin elevation, and no significant effects on FSH, LH, TSH, or ACTH at therapeutic dosages
Avinoam, S.P., Kowalski, H.R., Chaya, B.F
This sparked further advancements, including Novo Nordisks development of more potent analogs like liraglutide and semaglutide, with the latter achieving over $12 billion in sales by 2022
Available online at: (Accessed June 21, 2025)
About the brand Life Extension is a company that focuses on quality, purity and potential
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: A physiological approach toward improved metabolic control